|
|
Emergency Filtration Products Launches E.L.V.I.S at NAEMT& EMS Expo in Las Vegas Henderson, Nevada –September 27, 2006 -- Emergency Filtration Products, Inc. (EFP) (OTCBB: EMFP) today launched E.L.V.I.S., (Emergency Life-support Ventilation and Intubation System) at the NAEMT (National Association of Emergency Medical Technicians) & EMS (Emergency Medical Services) Expo in Las Vegas, Nevada. EFP's ELVIS is a best-of-breed emergency resuscitation system with essential integrated features, including a patented medication/suction port, a self-contained nebulizer and a 2H Technology™ air filtration system that reduces exposure to infectious agents. ELVIS will be marketed to the U.S. Military, hospitals, police and fire departments and emergency response teams nationwide. ELVIS has been endorsed by Catholic Healthcare West (see below) and the City of Los Angeles Police Department. The company intends to apply for fast-track FDA approval. Based on current indications of interest for this product, the company is planning for an initial production run of 10,000 units. The preliminary suggested retail-selling price for the product is $24.95. About Emergency Filtration Products, Inc.: EFP is an air filtration products manufacturer who's patented 2H Technology™ filter system has produced filtration efficiencies of 'greater than 99.99%' at a particulate size of 0.027 microns. EFP's initial products were developed for the medical market: the Vapor Isolation Valve™ and RespAide® CPR Isolation Mask used for resuscitation of respiratory/cardiac arrest cases; and 2H Breathing Circuit Filter for ventilators, respirators and anesthesia circuitry. Each has received FDA approval. The Company Safe Harbor Statement: This release may contain statements that are forward looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. EFP does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future results of the company could differ significantly from such forward-looking statements. Specifically, successful production of the NanoMask products may not translate into significant sales. Sales may be dependent on the success of future marketing campaigns, and both the perceived need for EFP's products and the competitive performance of such products in the marketplace. For Further Information on EFP: Emergency Filtration Products: or |
||